Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study.
Tanabe K, Kobayashi S, Maezawa Y, Ishihara K, Inoue N, Izumi K, Fujiwara M, Toide M, Yamamoto T, Uehara S, Araki S, Inoue M, Takazawa R, Numao N, Ohtsuka Y, Tanaka H, Yoshida S, Fujii Y.
Tanabe K, et al. Among authors: yoshida s.
Int J Clin Oncol. 2024 Jun 4. doi: 10.1007/s10147-024-02563-7. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 38833113